2017 Vaccines Process Development & Commercialization Workshop

June 27-29, 2017 • MIT, Cambridge, MA

Massachusetts Institute of Technology in collaboration with University College London is announcing its 2017 Vaccines Bioprocess Development & Commercialization Workshop.

This three day workshop will explore the critical issues at the various stages of vaccine development. International experts with over 10 years’ experience in their field will lead delegates in developing their understanding in the research, operational and regulatory challenges of the vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about manufacturing at-risk with real examples from the influenza manufacturing process.


June 27 Speakers Tarit Mukhopadhyay, UCL Stephen Hadley, Bill & Melinda Gates Foundation Barry Buckland, BiologicB, LLC Stacy L. Springs, MIT Derek O'Hagan, GSK Charles L. Cooney, MIT	June 28 Speakers Alain Pralong, Cell Medica Ltd. Stephen A. Kolodziej, Pfizer, Inc. Robert Sitrin, PATH John Aunins, SERES Martin Wisher, BioReliance José Castillo, Univercells Matthew Downham, AstraZeneca	June 29 Keynote Mark Feinberg, IAVI Speakers Tarit Mukhopadhyay, UCL J. Christopher Love, MIT Dan Barouch, Harvard Adrian Hill, Oxford Panel Discussion: CMC Regulatory Challenges Panel Members Include: Robin Levis, FDA David Robinson, previously Merck Wim Van Molle, Scientific Institute of Public Health, Wetenschappelijk Instituut Volksgezondheid

This workshop is suitable for:

Scientists new to the vaccines sector (recent graduates / research scientists).
Scientists and technical managers who wish to broaden their knowledge in various vaccine technologies and platforms, exploring the interplay between process choices and regulation.
Project Managers, funders and policy-makers wanting to gain an understanding in vaccines.